These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27720342)

  • 61. Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia.
    Shrestha AC; Field E; Rajmokan M; Lambert SB
    Vaccine; 2023 Dec; 41(50):7539-7547. PubMed ID: 37980260
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions--United States, 2010.
    Lu PJ; Gonzalez-Feliciano A; Ding H; Bryan LN; Yankey D; Monsell EA; Greby SM; Euler GL
    Am J Infect Control; 2013 Aug; 41(8):702-9. PubMed ID: 23419613
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Noninfluenza vaccination coverage among adults - United States, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Feb; 62(4):66-72. PubMed ID: 23364272
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential uptake of herpes zoster vaccination associated with socioeconomic status: A population-based study in Stockholm County, Sweden.
    Fogelberg S; Lamb F; Grönlund O; Eriksson I; Sundström K; Clements M; Arnheim-Dahlström L
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1159-1165. PubMed ID: 30221421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
    Nicholls LAB; Gallant AJ; Cogan N; Rasmussen S; Young D; Williams L
    Vaccine; 2021 Jun; 39(26):3520-3527. PubMed ID: 34023136
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.
    Brotherton AL; Shah R
    R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
    Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
    Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.
    Schmader KE; Oxman MN; Levin MJ; Johnson G; Zhang JH; Betts R; Morrison VA; Gelb L; Guatelli JC; Harbecke R; Pachucki C; Keay S; Menzies B; Griffin MR; Kauffman C; Marques A; Toney J; Keller PM; Li X; Chan IS; Annunziato P;
    Clin Infect Dis; 2012 Nov; 55(10):1320-8. PubMed ID: 22828595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
    Miller G; Schaefer H; Yoder S; Miller R; Winokur P; Kotloff K; Klassen D; Wierzbicki M; Amegashie C; Edwards K
    Transpl Infect Dis; 2018 Jun; 20(3):e12874. PubMed ID: 29512282
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.
    Langan SM; Smeeth L; Margolis DJ; Thomas SL
    PLoS Med; 2013; 10(4):e1001420. PubMed ID: 23585738
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer.
    Curran D; Patterson BJ; Carrico J; Salem A; La EM; Lorenc S; Hicks KA; Poston S; Carpenter CF
    Hum Vaccin Immunother; 2023 Dec; 19(1):2167907. PubMed ID: 36880669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vaccination Coverage Among Adults Aged 65 and Over: United States, 2015.
    Norris T; Vahratian A; Cohen RA
    NCHS Data Brief; 2017 Jun; (281):1-8. PubMed ID: 28696200
    [TBL] [Abstract][Full Text] [Related]  

  • 74. State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.
    Ahluwalia IB; Mack KA; Murphy W; Mokdad AH; Bales VS
    MMWR Surveill Summ; 2003 Aug; 52(8):1-80. PubMed ID: 14532868
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factors influencing influenza, pneumococcal and shingles vaccine uptake and refusal in older adults: a population-based cross-sectional study in England.
    Tan PS; Patone M; Clift AK; Dambha-Miller H; Saatci D; Ranger TA; Garriga C; Zaccardi F; Shah BR; Coupland C; Griffin SJ; Khunti K; Hippisley-Cox J
    BMJ Open; 2023 Mar; 13(3):e058705. PubMed ID: 36927589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Zoster vaccine protects against shingles.
    BMJ; 2013 Apr; 346():f2389. PubMed ID: 23596220
    [No Abstract]   [Full Text] [Related]  

  • 77. Zoster vaccine live for the prevention of shingles in the elderly patient.
    Zussman J; Young L
    Clin Interv Aging; 2008; 3(2):241-50. PubMed ID: 18686747
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Harpaz R; Ortega-Sanchez IR; Seward JF;
    MMWR Recomm Rep; 2008 Jun; 57(RR-5):1-30; quiz CE2-4. PubMed ID: 18528318
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Shingles in Alberta: before and after publicly funded varicella vaccination.
    Russell ML; Dover DC; Simmonds KA; Svenson LW
    Vaccine; 2014 Oct; 32(47):6319-24. PubMed ID: 24099868
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Rothberg MB; Virapongse A; Smith KJ
    Clin Infect Dis; 2007 May; 44(10):1280-8. PubMed ID: 17443464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.